ONWARD: Up-LIFT reveals ARC-EX extraordinary neurological potential vs SOC
The so-awaited full disclosure of the ARC-EX Up-LIFT pivotal study materialized yesterday with its publication in the top-tier scientific journal - Nature (access here). Whilst the top-line data reported in April 2023 already validated ARC-EX Therapy efficacy hitting 72% responder rate, the extende
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.